If an oral version is released, its price will depend on manufacturing costs, insurance coverage, and market demand
Against this backdrop, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), first used for type 2 diabetes, have emerged as potent weight-loss agents with possible anti-inflammatory actions, making them attractive candidates in HS care
Animal models of heart failure: a scientific statement from the American Heart Association
Releases WADAs 2026 Prohibited List is now in force The World Anti-Doping Agency (WADA) wishes to remind stakeholders that the 2026 List of Prohibited Substances and Methods (List) and the 2026 Monitoring Program are now in force as of today (1 January 2026)
Focus on easily digestible options such as white rice, fruit, potatoes, non-cruciferous vegetables, and lean proteins like white fish or minced meat
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years